Skip to main content
FinSpry Logo
FinSpry
KRYS logo
KRYS
(NASDAQ)
Krystal Biotech, Inc.
$326.45-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Krystal Biotech (KRYS) Stock Price & Financial Analysis

Krystal Biotech Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$324.32 - $336.28
52-Week High$382.54
52-Week Low$136.73
Open$333.30
Volume147.88K
Average Volume (3M)518.88K
Market Cap9.96B
Shares Outstanding30.51M
P/E Ratio (TTM)44.26
Forward P/E23.98
Price to Sales (P/S)23.87
Price to Book (P/B)7.80
EV/EBITDA52.93
Revenue (TTM)417.30M
Net Income (TTM)225.03M
Free Cash Flow (TTM)237.38M
EPS (TTM)$7.50
Profit Margin53.92%
Operating Margin42.85%
Return on Equity (ROE)17.63%
Debt to Equity0.01
50-Day MA$339.73
200-Day MA$275.95
52-Week Change135.43%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Krystal Biotech

What is the current stock price for KRYS?

As of the latest trading session, KRYS stock trades at $327.05. The 52-week range is $136.73–$382.54, with a day range of $324.32–$336.28.

What is the P/E ratio for KRYS?

Krystal Biotech's trailing P/E ratio is 44.3, meaning investors pay $44.3 for every $1 of annual earnings. The forward P/E is 24.0, reflecting analyst expectations for future earnings. Krystal Biotech operates in the Healthcare sector.

Does KRYS pay dividends?

Krystal Biotech does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for KRYS?

Based on 4 analysts, the consensus for KRYS is Buy.

What is the market cap of KRYS?

Krystal Biotech's market capitalization is $9.98B, classifying it as a mid-cap company. Krystal Biotech operates in the Healthcare sector within the Biotechnology industry.